TAD offers a service of preliminary PK in immunocompetent and immunodecifient mice.

The service is intended to provide rapid assessments of the PK, in blood or target tissues, of new compounds administered to mice by any route.

This is an ideal solution, among other potential uses, to select the best compounds for or optimizing the design of the efficacy studies.

Don not hesitate to